Literature DB >> 1900151

Protease nexin-2/amyloid beta-protein precursor in blood is a platelet-specific protein.

W E Van Nostrand1, A H Schmaier, J S Farrow, D B Cines, D D Cunningham.   

Abstract

The protease inhibitor, protease nexin-2 (PN-2), is the secreted form of the amyloid beta-protein precursor (APP) which contains the Kunitz protease inhibitor domain. PN-2/APP is an abundant platelet alpha-granule protein which is secreted upon platelet activation. PN-2/APP mRNA is present in cultured endothelial cells and the protein has been detected in plasma. In the present studies we quantitated PN-2/APP in platelets, plasma and several different cell types of the vasculature to identify the repository of the protein in the circulatory system. We report that PN-2/APP is predominantly a platelet protein in the vascular compartment. Lysates of unstimulated umbilical vein endothelial cells, granulocytes or monocytes contained little PN-2/APP based on sensitive functional protease binding and immunoblotting assays. Quantitative immunoblotting studies demonstrated that normal citrated-plasma contains less than or equal to 60 pM PN-2/APP. In contrast, platelets can contribute up to 30 nM PN-2/APP, indicating that they are the major source of the protein in blood.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1900151     DOI: 10.1016/s0006-291x(05)81193-3

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Can platelet BACE1 levels be used as a biomarker for Alzheimer's disease? Proof-of-concept study.

Authors:  Boris Decourt; Aaron Walker; Amanda Gonzales; Michael Malek-Ahmadi; Carolyn Liesback; Kathryn J Davis; Christine M Belden; Sandra A Jacobson; Marwan N Sabbagh
Journal:  Platelets       Date:  2012-07-09       Impact factor: 3.862

Review 2.  Platelets and Alzheimer's disease: Potential of APP as a biomarker.

Authors:  Geneviève Evin; Qiao-Xin Li
Journal:  World J Psychiatry       Date:  2012-12-22

3.  Mutation of the Kunitz-type proteinase inhibitor domain in the amyloid β-protein precursor abolishes its anti-thrombotic properties in vivo.

Authors:  Feng Xu; Judianne Davis; Michael Hoos; William E Van Nostrand
Journal:  Thromb Res       Date:  2017-05-04       Impact factor: 3.944

Review 4.  The role of beta-amyloid peptide in Alzheimer's disease.

Authors:  A LeBlanc
Journal:  Metab Brain Dis       Date:  1994-03       Impact factor: 3.584

5.  Platelets are responsible for the accumulation of β-amyloid in blood clots inside and around blood vessels in mouse brain after thrombosis.

Authors:  Lilia Y Kucheryavykh; Josué Dávila-Rodríguez; David E Rivera-Aponte; Lidia V Zueva; A Valance Washington; Priscilla Sanabria; Mikhail Y Inyushin
Journal:  Brain Res Bull       Date:  2016-11-28       Impact factor: 4.077

6.  Bleeding is increased in amyloid precursor protein knockout mouse.

Authors:  Nima Mazinani; Amy W Strilchuk; James R Baylis; Woosuk S Hur; Wilfred A Jefferies; Christian J Kastrup
Journal:  Res Pract Thromb Haemost       Date:  2020-06-14

7.  Protease nexin-2/amyloid beta protein precursor. A tight-binding inhibitor of coagulation factor IXa.

Authors:  A H Schmaier; L D Dahl; A J Rozemuller; R A Roos; S L Wagner; R Chung; W E Van Nostrand
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

8.  Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease.

Authors:  Alex E Roher; Chera L Esh; Tyler A Kokjohn; Eduardo M Castaño; Gregory D Van Vickle; Walter M Kalback; R Lyle Patton; Dean C Luehrs; Ian D Daugs; Yu-Min Kuo; Mark R Emmerling; Holly Soares; Joseph F Quinn; Jeffrey Kaye; Donald J Connor; Nina B Silverberg; Charles H Adler; James D Seward; Thomas G Beach; Marwan N Sabbagh
Journal:  Alzheimers Dement       Date:  2009-01       Impact factor: 21.566

Review 9.  Insights into the physiological function of the β-amyloid precursor protein: beyond Alzheimer's disease.

Authors:  Edgar Dawkins; David H Small
Journal:  J Neurochem       Date:  2014-03-07       Impact factor: 5.372

10.  Amyloid Beta Peptide Is Released during Thrombosis in the Skin.

Authors:  Lilia Y Kucheryavykh; Yuriy V Kucheryavykh; A Valance Washington; Mikhail Y Inyushin
Journal:  Int J Mol Sci       Date:  2018-06-08       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.